3 Unstoppable Stocks to Buy in 2026 and Hold Forever

Source The Motley Fool

Key Points

  • Eli Lilly is a top healthcare company that's not only generating impressive growth right now, but continuing to invest in its future.

  • American Express' strong brand and clientele make it a resilient financial stock to invest in for the long haul.

  • Alphabet's varied businesses, plentiful growth opportunities, and deep pockets make it highly likely that it remains a growth beast for the foreseeable future.

  • 10 stocks we like better than Eli Lilly ›

If you want to invest in strong stocks that you can hold on to forever, it's important to consider not only what their financials look like today, but also the strength of their overall business models, and what their futures may look like. By doing this, you can ensure you're thinking about the big picture, and whether a company can succeed in the long haul.

Three businesses that I think are solid investments with terrific financials and growth prospects that you can safely buy today and hang on to forever are Eli Lilly (NYSE: LLY), American Express (NYSE: AXP), and Alphabet (NASDAQ: GOOG)(NASDAQ: GOOGL).

Where to invest $1,000 right now? Our analyst team just revealed what they believe are the 10 best stocks to buy right now, when you join Stock Advisor. See the stocks »

A family reviewing financial results with an advisor.

Image source: Getty Images.

Eli Lilly

Eli Lilly is a growth machine, and it's the type of business you can feel comfortable owning due to its relentless pursuit of innovation. Even though the healthcare company is generating stellar results these days thanks to its fantastic GLP-1 products -- Mounjaro (for diabetes) and Zepbound (for weight loss) -- it's still innovating. The company is working on bringing a GLP-1 pill to market and arguably its most promising weight loss treatment, retatrutide, is in late-stage trials and may obtain approval in the near future.

The company has also agreed to partner with tech giant Nvidia to build a factory that will utilize artificial intelligence and a supercomputer to help accelerate drug discovery. It could take years for the project to pay off and lead to tangible results, but it's an excellent example of the company's appetite for more growth.

While GLP-1 drugs have made the stock a hot buy in recent years, Eli Lilly's business is broader than that drug class alone. It also has a treatment approved for early Alzheimer's, Kisunla, which could be a potential blockbuster for the business.

Although the stock isn't cheap, as it trades at more than 50 times its trailing earnings, with so much growth still ahead for Eli Lilly, that multiple could come down significantly in the future. As the business gets bigger and continues growing, so too will its valuation. This is one of the safest healthcare stocks you can own today.

American Express

Credit card issuers can make for great investments as these businesses enjoy strong recurring revenue over the years. And what's attractive about American Express in particular is its focus on a more affluent customer base. The company's clientele may make the business less susceptible to downturns in the economy. And it has established a strong brand over the years, with its credit cards known for their attractive rewards and perks.

Even now, with consumers reportedly pulling back on discretionary purchases, Amex's business looks solid. Through the first nine months of 2025, the company reported revenue of $53.2 billion, which rose 9% year over year. And its net income of $8.4 billion was up by 5%.

American Express' strong financials and overall resiliency make it one of the best financial stocks to own for the long haul. Under stronger economic conditions, the business is likely to perform even better. And yet, over the past year, the stock has still risen by more than 20%.

Alphabet

Undoubtedly, one of the best growth stocks to own is Alphabet, the company that owns Waymo, Google, YouTube, Gemini, and other excellent assets. It has an abundance of growth opportunities that make it a no-brainer buy for long-term investors.

It has generated an incredible $124.3 billion in earnings over the past four quarters, with its profit margin coming in at an impressive rate of 32%. With those kinds of profits and margins, the company can afford to take on big acquisitions and pursue risky initiatives that other businesses may not be able to.

It's the second-most valuable stock in the world today with a market cap of $4 trillion, trailing only Nvidia. But with exceptional growth prospects and solid fundamentals, it can still have plenty of room to rise even further in the long run.

Should you buy stock in Eli Lilly right now?

Before you buy stock in Eli Lilly, consider this:

The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Eli Lilly wasn’t one of them. The 10 stocks that made the cut could produce monster returns in the coming years.

Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you’d have $477,544!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you’d have $1,122,686!*

Now, it’s worth noting Stock Advisor’s total average return is 952% — a market-crushing outperformance compared to 195% for the S&P 500. Don't miss the latest top 10 list, available with Stock Advisor, and join an investing community built by individual investors for individual investors.

See the 10 stocks »

*Stock Advisor returns as of January 15, 2026.

American Express is an advertising partner of Motley Fool Money. David Jagielski, CPA has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Alphabet and Nvidia. The Motley Fool has a disclosure policy.

Disclaimer: For information purposes only. Past performance is not indicative of future results.
placeholder
My Top 5 Stock Market Predictions for 2026Five 2026 market predictions written in a native, news-style voice: AI’s winners and losers, broader sector leadership, dividend demand, valuation cooling as the Shiller CAPE sits at 39 (Dec. 31, 2025), and quantum-computing bursts—while keeping all original facts and numbers unchanged.
Author  Mitrade
Jan 06, Tue
Five 2026 market predictions written in a native, news-style voice: AI’s winners and losers, broader sector leadership, dividend demand, valuation cooling as the Shiller CAPE sits at 39 (Dec. 31, 2025), and quantum-computing bursts—while keeping all original facts and numbers unchanged.
placeholder
Bitcoin shows strong correlation with institutional demand following 7% uptickBitcoin's price has largely tracked net institutional demand over the past year, according to Bitwise. Net institutional demand is the buying activity of global exchange-traded products (ETPs) and treasury companies minus new supply.
Author  FXStreet
Yesterday 01: 37
Bitcoin's price has largely tracked net institutional demand over the past year, according to Bitwise. Net institutional demand is the buying activity of global exchange-traded products (ETPs) and treasury companies minus new supply.
placeholder
Silver Price Forecast: XAG/USD corrects to near $86.50 as Iran stops killing protestersSilver price corrects almost 6% to near $86.50 during the Asian trading session on Thursday.
Author  FXStreet
21 hours ago
Silver price corrects almost 6% to near $86.50 during the Asian trading session on Thursday.
placeholder
Standard Chartered lifts Ethereum call to $7,500, arguing institutional demand could leave Bitcoin trailingStandard Chartered raised its year-end Ethereum target to $7,500 (from $4,000), citing institutional demand, while projecting $25,000 by 2028 and scenarios toward $40,000 by 2030 amid ETF- and treasury-driven accumulation.
Author  Mitrade
20 hours ago
Standard Chartered raised its year-end Ethereum target to $7,500 (from $4,000), citing institutional demand, while projecting $25,000 by 2028 and scenarios toward $40,000 by 2030 amid ETF- and treasury-driven accumulation.
placeholder
Bitcoin Hits $97K Despite Elevated PPI and Lack of US Tariff DecisionDespite higher-than-expected Producer Price Index (PPI) inflation data for November, Bitcoin surged to new eight-week highs, diverging from US stock markets.
Author  Mitrade
17 hours ago
Despite higher-than-expected Producer Price Index (PPI) inflation data for November, Bitcoin surged to new eight-week highs, diverging from US stock markets.
goTop
quote